Full Name
Gaik Ming, Melissa Ooi
Main Affiliation
 
 
Email
mdcogmm@nus.edu.sg
 

Publications

Results 1-9 of 9 (Search time: 0.04 seconds).

Issue DateTitleAuthor(s)
120-Sep-2018Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisTeoh, Phaik Ju ; An, Omer ; Chung, Tae-Hoon ; Chooi, Jing Yuan ; Toh, Sabrina HM ; Fan, Shuangyi ; Wang, Wilson ; Koh, Bryan TH; Fullwood, Melissa J ; Ooi, Melissa G ; de Mel, Sanjay; Soekojo, Cinnie Y; Chen, Leilei ; Ng, Siok Bian ; Yang, Henry ; Chng, Wee Joo 
21-Mar-2021Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysisChong, Lip Leong; Soon, Yu Yang ; Soekojo, Cinnie Yentia; Ooi, Melissa ; Chng, Wee Joo ; de Mel, Sanjay
31-Mar-2020Immunotherapy in Multiple MyelomaSoekojo, Cinnie Yentia; Ooi, Melissa ; de Mel, Sanjay; Chng, Wee Joo 
42011Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translationMcMillin D.W.; Delmore J.; Negri J.; Ooi M. ; Klippel S.; Miduturu C.V.; Gray N.S.; Richardson P.G.; Anderson K.C.; Kung A.L.; Mitsiades C.S.
526-May-2022Pan-cancer pervasive upregulation of 3 ' UTR splicing drives tumourigenesisChan, Jia Jia ; Zhang, Bin ; Chew, Xiao Hong ; Salhi, Adil; Kwok, Zhi Hao; Lim, Chun You ; Desi, Ng ; Subramaniam, Nagavidya; Siemens, Angela; Kinanti, Tyas; Ong, Shane; Sanchez-Mejias, Avencia ; Ly, Phuong Thao; An, Omer ; Sundar, Raghav; Fan, Xiaonan ; Wang, Shi ; Siew, Bei En ; Lee, Kuok Chung; Chong, Choon Seng ; Lieske, Bettina ; Cheong, Wai-Kit; Goh, Yufen ; Fam, Wee Nih ; Ooi, Melissa G ; Koh, Bryan TH; Iyer, Shridhar Ganpathi ; Ling, Wen Huan ; Chen, Jianbin ; Yoong, Boon-Koon; Chanwat, Rawisak; Bonney, Glenn Kunnath; Goh, Brian KP ; Zhai, Weiwei; Fullwood, Melissa J ; Wang, Wilson ; Tan, Ker-Kan ; Chng, Wee Joo ; Dan, Yock Young ; Pitt, Jason J ; Roca, Xavier; Guccione, Ernesto ; Vardy, Leah A; Chen, Leilei ; Gao, Xin; Chow, Pierce KH ; Yang, Henry; Tay, Yvonne 
63-Sep-2021A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)Chen, Yunxin ; Gopalakrishnan, Sathish Kumar; Ooi, Melissa ; Sultana, Rehena ; Lim, Li Hui; Grigoropoulos, Nicholas ; Ong, Shin Yeu ; Xu, Mingge; Chng, Wee Joo ; Goh, Yeow Tee ; Nagarajan, Chandramouli
72018Potential clinical application of genomics in multiple myelomaSoekojo, C.Y; de Mel, S; Ooi, M ; Yan, B; Chng, W.J 
82020Relationship of JAK2 (V617F) allelic burden with clinico-haematological manifestations of philadelphia-negative myeloproliferative neoplasmsYow, K.S.; Liu, X.; Chai, C.N.; Tung, M.L. ; Yan, B.; Christopher, D.; Ong, K.H.; Ooi, M.G. 
92016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K